financetom
Business
financetom
/
Business
/
Shore Bancshares Files $175 Million Mixed Shelf
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shore Bancshares Files $175 Million Mixed Shelf
May 16, 2024 3:10 PM

05:46 PM EDT, 05/16/2024 (MT Newswires) -- Shore Bancshares ( SHBI ) on Thursday filed a registration statement with the US Securities and Exchange Commission covering the potential sale of securities for up to $175 million from time to time in one or more offerings.

The filing covers common stock, preferred stock, depositary shares, debt securities, warrants and units.

The company plans to use the net proceeds from the sale of securities for general corporate purposes, including acquisitions, capital expenses, investments, repayment or refinancing of debt and borrowings.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Block's Ticker Symbols to Change on NYSE and ASX
Block's Ticker Symbols to Change on NYSE and ASX
Jan 9, 2025
05:19 PM EST, 01/09/2025 (MT Newswires) -- Block (SQ) said Thursday it will change its ticker symbols from SQ and SQ2 to XYZ. The ticker changes on the company's dual listings on the New York Stock Exchange and the Australian Securities Exchange are effective Jan. 21. Block's common shares will start trading under the new symbol effective Jan. 22, according...
Brookdale Senior Living Reports Increase in December Occupancy
Brookdale Senior Living Reports Increase in December Occupancy
Jan 9, 2025
05:22 PM EST, 01/09/2025 (MT Newswires) -- Brookdale Senior Living ( BKD ) said Thursday that December weighted average occupancy rose 100 basis points year-over-year to 79.3%. The Q4 weighted average occupancy rose 100 basis points from a year earlier and 50 basis points from Q3, the company said. ...
Intellia Therapeutics to Workforce by 27%, Halt Some Programs
Intellia Therapeutics to Workforce by 27%, Halt Some Programs
Jan 9, 2025
05:24 PM EST, 01/09/2025 (MT Newswires) -- Intellia Therapeutics ( NTLA ) plans to cut its workforce by 27% to cuts costs and stop development of NTLA-3001 to treat alpha-1 antitrypsin deficiency-associated lung disease and halt some research-stage programs. Resources will be focused on NTLA-2002 for hereditary angioedema and nexiguran ziclumeran for transthyretin amyloidosis, the company said Thursday in a...
Repare Therapeutics to Refocus Resources on Advancing 2 Phase 1 Clinical Trials
Repare Therapeutics to Refocus Resources on Advancing 2 Phase 1 Clinical Trials
Jan 9, 2025
05:23 PM EST, 01/09/2025 (MT Newswires) -- Repare Therapeutics ( RPTX ) said late Thursday it is refocusing its resources on advancing phase 1 clinical programs for RP-1664 in solid tumors and RP-3467 in certain types of cancer. The company also intends to seek partnerships for lunresertib and camonsertib before starting the next trials. The strategic realignment, combined with cost...
Copyright 2023-2026 - www.financetom.com All Rights Reserved